MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Uncommon Presentation of Moyamoya Disease (MMD): A Case of Negative Myoclonus

S. Park (Daejeon, Republic of Korea)

Meeting: 2025 International Congress

Keywords: Myoclonus: Clinical features, Myoclonus: Etiology and Pathogenesis

Category: Myoclonus/Tics/Stereotypies

Objective: We describe a case of MMD in which the patient presented with negative myoclonus.

Background: Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized by occlusion of the terminal portions of the internal carotid arteries. The clinical manifestations of MMD present with various neurological symptoms, most commonly stroke. However, in rare cases, MMD may present as a movement disorder.

Method: A 42-year-old man presented with intermittent involuntary movements several months ago. These neurologic symptoms were triggered by tension or excitement. Distinct involuntary movements were not observed during the outpatient clinic, and other neurological abnormalities were normal. However, a personal video recorded by the patient revealed negative myoclonus in both upper extremities. There was no familial history of similar symptoms.

Results: Brain magnetic resonance (MR) imaging showed diffuse, irregular, and prominent leptomeningeal enhancement (right > left) on the gadolinium-enhanced T1-weighted image referred to as “ivy signs”. Brain MR angiography demonstrated near-total occlusions of both distal internal carotid arteries to middle cerebral arteries (MCA, right > left), with the posterior cerebral artery also involved, along with supplementary abnormal vessels. Perfusion MR demonstrated widely prolonged mean transit time in both hemispheres. Electroencephalography showed normal findings. Genetic analysis identified a pathogenic RNF213 gene variation: NM_001256071.1: c.14429G>A (p.Arg4810Lys). Other laboratory tests for vasculitis were normal. The patient was diagnosed with MMD and underwent a right superficial temporal artery-MCA bypass surgery.

Conclusion: In this case, it is critical not to overlook MMD during the initial diagnosis. Therefore, if a patient presents with unexplained movement disorders, it is important to clearly assess the symptoms through methods such as personal videos and perform brain imaging to make an accurate diagnosis. Specifically, contrast-enhanced brain imaging are crucial for identifying any abnormalities in the cerebral vessels.

To cite this abstract in AMA style:

S. Park. Uncommon Presentation of Moyamoya Disease (MMD): A Case of Negative Myoclonus [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/uncommon-presentation-of-moyamoya-disease-mmd-a-case-of-negative-myoclonus/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/uncommon-presentation-of-moyamoya-disease-mmd-a-case-of-negative-myoclonus/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley